SLC25A37

Chr 8

solute carrier family 25 member 37

Also known as: HT015, MFRN, MFRN1, MSCP

SLC25A37 encodes a mitochondrial iron transporter that mediates iron uptake in developing erythroid cells and is essential for heme biosynthesis and iron-sulfur cluster synthesis. Mutations cause autosomal recessive sideroblastic anemia, characterized by defective heme synthesis and abnormal iron accumulation in developing red blood cells. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.63), reflecting its important role in cellular iron metabolism.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
14
Pubs (1 yr)
81
P/LP submissions
0%
P/LP missense
0.63
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLC25A37
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.
📋
ClinVar Variants
81 unique Pathogenic / Likely Pathogenic· 57 VUS of 146 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.63LOEUF
pLI 0.279
Z-score 2.45
OE 0.24 (0.110.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.10Z-score
OE missense 0.79 (0.700.90)
171 obs / 216.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.24 (0.110.63)
00.351.4
Missense OE0.79 (0.700.90)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 3 / 12.3Missense obs/exp: 171 / 216.7Syn Z: -0.06
DN
0.80top 10%
GOF
0.7127th %ile
LOF
0.3355th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

146 submitted variants in ClinVar

Classification Summary

Pathogenic77
Likely Pathogenic4
VUS57
Likely Benign1
Benign2
77
Pathogenic
4
Likely Pathogenic
57
VUS
1
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
77
0
77
Likely Pathogenic
0
0
4
0
4
VUS
0
54
3
0
57
Likely Benign
0
0
0
1
1
Benign
0
1
0
1
2
Total055842141

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC25A37 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →